Scan-Kill A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.8% 3.1% 3.1% 42.2% 17.1%  
Credit score (0-100)  51 54 56 0 10  
Credit rating  BBB BBB BBB C BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  4,609 4,891 5,394 2,535 6,087  
EBITDA  1,481 1,617 1,607 -1,741 2,333  
EBIT  592 710 856 -2,329 1,819  
Pre-tax profit (PTP)  565.0 670.4 824.2 -2,355.9 1,810.7  
Net earnings  428.4 509.7 624.0 -1,855.1 1,382.3  
Pre-tax profit without non-rec. items  565 670 824 -2,356 1,811  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  1,453 1,471 1,008 718 399  
Shareholders equity total  1,440 1,550 1,624 -855 -294  
Interest-bearing liabilities  773 1,273 520 10.4 2.6  
Balance sheet total (assets)  4,413 3,910 3,043 3,481 3,612  

Net Debt  -55.8 1,191 481 -60.0 -985  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,609 4,891 5,394 2,535 6,087  
Gross profit growth  12.8% 6.1% 10.3% -53.0% 140.1%  
Employees  6 7 7 7 7  
Employee growth %  -7.7% 16.7% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,413 3,910 3,043 3,481 3,612  
Balance sheet change%  32.7% -11.4% -22.2% 14.4% 3.8%  
Added value  1,480.9 1,617.2 1,606.9 -1,577.9 2,332.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,126 -1,021 -1,347 -1,010 -965  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  12.8% 14.5% 15.9% -91.9% 29.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.5% 17.2% 24.9% -62.8% 44.4%  
ROI %  23.1% 24.9% 31.6% -186.5% 2,535.5%  
ROE %  34.9% 34.1% 39.3% -72.7% 39.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  32.6% 39.6% 53.4% -19.7% -7.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -3.8% 73.7% 29.9% 3.4% -42.2%  
Gearing %  53.7% 82.1% 32.0% -1.2% -0.9%  
Net interest  0 0 0 0 0  
Financing costs %  3.8% 4.3% 4.6% 14.1% 298.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.8 0.8 0.9 0.4 0.7  
Current Ratio  0.9 1.0 1.4 0.6 0.8  
Cash and cash equivalent  828.6 81.2 39.5 70.5 988.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -158.1 -44.0 525.8 -1,599.6 -718.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  247 231 230 -225 333  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  247 231 230 -249 333  
EBIT / employee  99 101 122 -333 260  
Net earnings / employee  71 73 89 -265 197